Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy.

Haas JA, Witten MR, Clancey O, Episcopia K, Accordino D, Chalas E.

Front Oncol. 2012 Mar 21;2:25. doi: 10.3389/fonc.2012.00025. eCollection 2012.

2.

Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer.

Cengiz M, Dogan A, Ozyigit G, Erturk E, Yildiz F, Selek U, Ulger S, Colak F, Zorlu F.

Brachytherapy. 2012 Mar-Apr;11(2):125-9. doi: 10.1016/j.brachy.2011.12.001. Epub 2011 Dec 20.

PMID:
22192496
3.

Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.

Fokdal L, Tanderup K, Nielsen SK, Christensen HK, Røhl L, Pedersen EM, Schønemann NK, Lindegaard JC.

Radiother Oncol. 2011 Sep;100(3):473-9. doi: 10.1016/j.radonc.2011.08.016. Epub 2011 Sep 15.

PMID:
21924784
4.

Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.

Pötter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, Georg D, Schmid MP, Reinthaller A, Sturdza A, Kirisits C.

Radiother Oncol. 2011 Jul;100(1):116-23. doi: 10.1016/j.radonc.2011.07.012. Epub 2011 Aug 5.

5.

Should helical tomotherapy replace brachytherapy for cervical cancer? Case report.

Hsieh CH, Wei MC, Hsu YP, Chong NS, Chen YJ, Hsiao SM, Hsieh YP, Wang LY, Shueng PW.

BMC Cancer. 2010 Nov 23;10:637. doi: 10.1186/1471-2407-10-637.

6.

High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.

Wang X, Liu R, Ma B, Yang K, Tian J, Jiang L, Bai ZG, Hao XY, Wang J, Li J, Sun SL, Yin H.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007563. doi: 10.1002/14651858.CD007563.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD007563.

PMID:
20614461
7.

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer.

Lim K, Small W Jr, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A; Gyn IMRT Consortium.

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):348-55. doi: 10.1016/j.ijrobp.2009.10.075. Epub 2010 May 14.

PMID:
20472347
8.

Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques.

Purdy JA.

Health Phys. 2008 Nov;95(5):666-76. doi: 10.1097/01.HP.0000326342.47348.06. Review.

PMID:
18849701
9.

Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study.

Chan P, Dinniwell R, Haider MA, Cho YB, Jaffray D, Lockwood G, Levin W, Manchul L, Fyles A, Milosevic M.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1507-15. doi: 10.1016/j.ijrobp.2007.08.055. Epub 2007 Dec 31.

PMID:
18164850
10.

A treatment planning study comparing HDR and AGIMRT for cervical cancer.

Wahab SH, Malyapa RS, Mutic S, Grigsby PW, Deasy JO, Miller TR, Zoberi I, Low DA.

Med Phys. 2004 Apr;31(4):734-43.

PMID:
15124990
11.

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.

J Clin Oncol. 2004 Mar 1;22(5):872-80.

PMID:
14990643
12.

The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.

Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ.

Radiother Oncol. 2003 Apr;67(1):69-76.

PMID:
12758242
13.

Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Hall EJ, Wuu CS.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):83-8. Review.

PMID:
12694826
14.

Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.

Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, MacLean G, Souhami L, Stuart G, Tu D.

J Clin Oncol. 2002 Feb 15;20(4):966-72.

PMID:
11844818
16.

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S.

N Engl J Med. 1999 Apr 15;340(15):1144-53. Erratum in: N Engl J Med 1999 Aug 26;341(9):708.

17.
18.

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.

Lanciano RM, Pajak TF, Martz K, Hanks GE.

Int J Radiat Oncol Biol Phys. 1993 Feb 15;25(3):391-7.

PMID:
8436516
19.

Supplemental Content

Support Center